Preformed Line Products PLPC Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

TRV

Trevi Therapeutics, Inc.TRVI

$0—

Rumble, Inc.RUM

$29.43M+32,132%

MBX Biosciences, Inc.MBX

$378K—

NovaGold ResourcesNG

$0-100%

Essential Properties Realty TrustEPRT

$152K-35.6%

First Busey CorporationBUSE

$0-100%

Other financials

Income statement

See full

Revenue$176.3M+18.7%

Gross profit$55.2M+13.5%

Operating income$13.7M+4.5%

Net income$10.5M-8.6%

EPS (diluted)$2.14-8.2%

Balance sheet

See full

Cash & equivalents$69.5M+26.7%

Total debt$43.1M+8.5%

Total equity$473.5M+8.7%

Total assets$661.8M+11.7%

Cash flow

See full

Operating cash flow$6.0M+6.9%

CapEx$10.0M-9.0%

Free cash flow-$3.9M+25.8%

Valuation

See full

Market cap$1.88B+91.5%

Profitability

See full

Gross margin30.9%-1.5pp

Operating margin8%-0.7pp

Net margin4.9%-1.6pp

FCF margin5%-2.6pp

Returns & leverage

See full

Return on equity7.5%-1.6pp

Debt / equity0.1×0.0×

Current ratio3×-0.1×

Where this comes from

Reported directly by Preformed Line Products in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Preformed Line Products’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Preformed Line Products's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Preformed Line Products's payments of stock issuance costs?: Preformed Line Products (PLPC) reported payments of stock issuance costs of $3.94M in Q1 2026.
How has Preformed Line Products's payments of stock issuance costs changed year-over-year?: Preformed Line Products's payments of stock issuance costs increased by 3.6% year-over-year, from $3.8M to $3.94M.